Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A survey of local health departments reveals concerning news—and a silver lining.
Yes! Here’s a snapshot of HIV providers responding to the new pandemic.
A systematic review of hep C treatment outcomes in this population shows they have high cure rates and relatively low reinfection rates.
Researchers examined increasing use of PrEP, expanding access to opioid use disorder treatment and improving engagement with HIV care.
Federal judge rules in favor of nonprofit seeking to open the country’s first overdose prevention facility.
A recent survey found that pharmacies are insufficiently educating the public about unused opioid and antibiotic disposal.
Researchers believe that lack of economic opportunity drives an increase in opioid use among local residents.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
Taking opioids at the same time as benzodiazepines, such as Xanax and Ativan, is also associated with overdose.
MLB’s drug policy was updated in response to the overdose death of Los Angeles Angels pitcher Tyler Skaggs in July.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
The state will provide prisoners medication-assisted treatment to treat opioid use disorder and is creating more syringe services programs.
U.S. health care systems are seeking better solutions to the critical problem of drug diversion.
The drug can quickly reverse opioid-driven overdoses.
A literature review shows promising signs that teenagers, like adults, can benefit from methadone, buprenorphine and naltrexone.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.